Hydrogen use in urological disease models

Volume: 10 Number: 2 May 1, 2015
  • Ekrem Akdeniz
TR EN

Hydrogen use in urological disease models

Abstract

Ischemia-reperfusion injury in tissues leaving temporary or permanent damage patients’ health is closely related to the clinical situation. Free oxygen radicals plays an important role in the pathophysiology of ischemia-reperfusion injury. Hydroxyl ion is the most powerful free radical. Reducing hydrogen and hydroxyl ions selectively and with different tissue protective mechanisms makes preventive effect on ischaemia-reperfusion injury. Today, hydrogen is a powerful antioxidant that is done much research on the tissue protective effect. This study evaluated the clinical reflection of hydrogen is used in urologic diseases and their effects on the future were discussed.

Keywords

References

  1. Gardès-Albert M. Physico-chemical aspects of reactive oxygen species. Ann Pharm Fr 2006;64(6):365-72.
  2. Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T. Development of novel fluorescence probes that can reli- ably detect reactive oxygen species and distinguish specific species. J Biol Chem 2003;278(5):3170-5.
  3. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. Mitochondria and reactive oxygen species. Free Radic Biol Med 2009;47(4):333-43.
  4. Barbouti A, Doulias PT, Nousis L, Tenopoulou M, Galaris D. DNA damage and apoptosis in hydrogen peroxide-ex- posed Jurkat cells: bolus addition versus continuous gene- ration of H2O2. Free Radic Biol Med 2002;33(5):691-702.
  5. Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007;13:688–694.
  6. Buchholz BM, Kaczorowski DJ, Sugimoto R, et al. Hydro- gen inhalation ameliorates oxidative stress in transplan- tation induced intestinal graft injury. Am J Transplant 2008;8:2015–2024.
  7. Dixon BJ, Tang J, Zhang JH. The evolution of molecular hydrogen: a noteworthy potential therapy with clinical sig- nificance. Med Gas Res 2013;3(1):10-15.
  8. Levitt MD, Bond JH. Volume, composition, and source of intestinal gas. Gastroenterology 1970;59:921 – 929.

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Ekrem Akdeniz This is me

Publication Date

May 1, 2015

Submission Date

-

Acceptance Date

-

Published in Issue

Year 2015 Volume: 10 Number: 2

APA
Akdeniz, E. (2015). Hydrogen use in urological disease models. Yeni Üroloji Dergisi, 10(2), 68-73. https://izlik.org/JA25YD34BP
AMA
1.Akdeniz E. Hydrogen use in urological disease models. New J Urol. 2015;10(2):68-73. https://izlik.org/JA25YD34BP
Chicago
Akdeniz, Ekrem. 2015. “Hydrogen Use in Urological Disease Models”. Yeni Üroloji Dergisi 10 (2): 68-73. https://izlik.org/JA25YD34BP.
EndNote
Akdeniz E (May 1, 2015) Hydrogen use in urological disease models. Yeni Üroloji Dergisi 10 2 68–73.
IEEE
[1]E. Akdeniz, “Hydrogen use in urological disease models”, New J Urol., vol. 10, no. 2, pp. 68–73, May 2015, [Online]. Available: https://izlik.org/JA25YD34BP
ISNAD
Akdeniz, Ekrem. “Hydrogen Use in Urological Disease Models”. Yeni Üroloji Dergisi 10/2 (May 1, 2015): 68-73. https://izlik.org/JA25YD34BP.
JAMA
1.Akdeniz E. Hydrogen use in urological disease models. New J Urol. 2015;10:68–73.
MLA
Akdeniz, Ekrem. “Hydrogen Use in Urological Disease Models”. Yeni Üroloji Dergisi, vol. 10, no. 2, May 2015, pp. 68-73, https://izlik.org/JA25YD34BP.
Vancouver
1.Ekrem Akdeniz. Hydrogen use in urological disease models. New J Urol. [Internet]. 2015 May 1;10(2):68-73. Available from: https://izlik.org/JA25YD34BP